RxDoctor Payments Data

Anna Melnikoff, MD

Obstetrics & Gynecology · Chattanooga, TNNPI 1083078307

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 24.8% of the total. Reporting peaked in 2021 at $254 and has fallen 87.9% since, to $31 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in TN, where the typical reported total is $906.

$584in general payments, 2019–2025

Across 59 payments — averaging $9.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$145
  • Evofem Biosciences, Inc.$126
  • Sumitomo Pharma America, Inc.$82
  • Hologic Sales And Service, LLC$68
  • Amgen$38
  • Astellas Pharma US Inc$30
  • plus $95 from 6 others

What the payments were for

  • Food & beverage$584100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$584 in reported general payments places this provider in the 40th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee →

Medicare billing

Part B allowed, 2024
$12,928
Medicare patients
59
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol39$2,315

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Chattanooga

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →